These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 3539323)

  • 21. Immunotherapeutic strategies in neuroblastoma: antitumoral activity of deglycosylated Ricin A conjugated anti-GD2 antibodies and anti-CD3xanti-GD2 bispecific antibodies.
    Manzke O; Russello O; Leenen C; Diehl V; Bohlen H; Berthold F
    Med Pediatr Oncol; 2001 Jan; 36(1):185-9. PubMed ID: 11464879
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Preparation of an anti-human immunotoxin against bladder carcinoma and its in vitro targeting cytotoxicity].
    Zhao C
    Zhonghua Zhong Liu Za Zhi; 1992 Mar; 14(2):109-11. PubMed ID: 1618077
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Kinetics of protein synthesis inactivation in human T-lymphocytes by selective monoclonal antibody-ricin conjugates.
    Leonard JE; Wang QC; Kaplan NO; Royston I
    Cancer Res; 1985 Nov; 45(11 Pt 1):5263-9. PubMed ID: 3876881
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phase I trial of an anti-CD19 deglycosylated ricin A chain immunotoxin in non-Hodgkin's lymphoma: effect of an intensive schedule of administration.
    Conry RM; Khazaeli MB; Saleh MN; Ghetie V; Vitetta ES; Liu T; LoBuglio AF
    J Immunother Emphasis Tumor Immunol; 1995 Nov; 18(4):231-41. PubMed ID: 8680651
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of monoclonal antibodies for the development of breast cancer immunotoxins.
    Bjorn MJ; Ring D; Frankel A
    Cancer Res; 1985 Mar; 45(3):1214-21. PubMed ID: 3971370
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An immunotoxin composed of monoclonal anti-Thy 1.1 antibody and a ribosome-inactivating protein from Saponaria officinalis: potent antitumor effects in vitro and in vivo.
    Thorpe PE; Brown AN; Bremner JA; Foxwell BM; Stirpe F
    J Natl Cancer Inst; 1985 Jul; 75(1):151-9. PubMed ID: 3859688
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synergy of ricin A chain-containing immunotoxins and ricin B chain-containing immunotoxins in in vitro killing of neoplastic human B cells.
    Vitetta ES; Cushley W; Uhr JW
    Proc Natl Acad Sci U S A; 1983 Oct; 80(20):6332-5. PubMed ID: 6578512
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selective in vitro inhibition of an antibody response to purified acetylcholine receptor by using anti-idiotypic antibodies coupled to the A chain of ricin.
    DeShambo RM; Krolick KA
    J Immunol; 1986 Nov; 137(10):3135-9. PubMed ID: 3490511
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-B4-blocked ricin immunotoxin shows therapeutic efficacy in four different SCID mouse tumor models.
    Shah SA; Halloran PM; Ferris CA; Levine BA; Bourret LA; Goldmacher VS; Blättler WA
    Cancer Res; 1993 Mar; 53(6):1360-7. PubMed ID: 7680284
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of HIV tissue culture infection with monoclonal antibody-ricin A chain conjugates.
    Pincus SH; Wehrly K; Chesebro B
    J Immunol; 1989 May; 142(9):3070-5. PubMed ID: 2540236
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combined immunochemotherapy of human solid tumors in nude mice.
    Weil-Hillman G; Uckun FM; Manske JM; Vallera DA
    Cancer Res; 1987 Jan; 47(2):579-85. PubMed ID: 3491678
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Monoclonal antibody-ricin A chain conjugate selectively cytotoxic for cells bearing the common acute lymphoblastic leukemia antigen.
    Raso V; Ritz J; Basala M; Schlossman SF
    Cancer Res; 1982 Feb; 42(2):457-64. PubMed ID: 6948605
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Elimination of clonogenic T-leukemic cells from human bone marrow using anti-Mr 65,000 protein immunotoxins.
    Stong RC; Youle RJ; Vallera DA
    Cancer Res; 1984 Jul; 44(7):3000-6. PubMed ID: 6372999
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Selective killing of target cells by antibody-ricin A chain or antibody-gelonin hybrid molecules: comparison of cytotoxic potency and use in immunoselection procedures.
    Colombatti M; Nabholz M; Gros O; Bron C
    J Immunol; 1983 Dec; 131(6):3091-5. PubMed ID: 6139402
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro and in vivo antitumor activity of ZENECA ZD0490, a recombinant ricin A-chain immunotoxin for the treatment of colorectal cancer.
    Calvete JA; Newell DR; Wright AF; Rose MS
    Cancer Res; 1994 Sep; 54(17):4684-90. PubMed ID: 8062265
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evidence for a novel hybrid immunotoxin recognizing ricin A-chain by one antigen-combining site and a prostate-restricted antigen by the remaining antigen-combining site: potential for immunotherapy.
    Webb KS; Ware JL; Parks SF; Walther PJ; Paulson DF
    Cancer Treat Rep; 1985 Jun; 69(6):663-72. PubMed ID: 4040422
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Blocked and not blocked whole-ricin-antibody immunotoxins: intraperitoneal therapy of human tumour xenografted in nude mice.
    Brusa P; Pietribiasi F; Bussolati G; Dosio F; Arione R; Comoglio PM; Prat M; Cattel L
    Cancer Immunol Immunother; 1989; 29(3):185-92. PubMed ID: 2659170
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effects of cyclophosphamide on the toxicity and immunogenicity of ricin A chain immunotoxin in rats.
    Stoudemire JB; Mischak R; Foxall C; Harkonen WS; Del Rio M; Spitler LE
    Mol Biother; 1990 Sep; 2(3):179-84. PubMed ID: 2222902
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Production and preclinical use of a monoclonal immunotoxin against laryngeal cancer cells].
    Zenner HP
    Laryngol Rhinol Otol (Stuttg); 1984 Nov; 63(11):566-9. PubMed ID: 6521585
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human melanoma cell lines showing striking inherent differences in sensitivity to immunotoxins containing holotoxins.
    Godal A; Fodstad O; Morgan AC; Pihl A
    J Natl Cancer Inst; 1986 Dec; 77(6):1247-53. PubMed ID: 3491924
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.